Other studies showed that downregulation or complete knockout of NKG2D in mice resulted in an impaired immune response against tumor cells, higher expression levels of NKG2D ligands, and an increased incidence of certain tumors [21,22]. This evidence concerns the gene KLRK1 and neoplasm.